Pharmacology and Obesity Treatment · Journal article
Food Science and Technology · August 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a bench-top study evaluating physicochemical and sensory properties of three Garcinia-based gummy formulations and their in vitro pancreatic lipase inhibitory activity. Formulation F2 (G. parvifolia) showed the highest lipase inhibition, attributed to high total phenolic and flavonoid content, while F3 (blend) was most acceptable sensorily but showed intermediate inhibition. The work is exploratory and does not establish efficacy in humans or animals; bioavailability, stability, and physiological effects remain unstudied.
In vitro formulation and sensory evaluation study. Garcinia-based gummy formulations; no human or animal subjects enrolled. Intervention: Three gummy formulations: F1 (Garcinia gummi-gutta), F2 (Garcinia parvifolia), F3 (G. gummi-gutta and G. parvifolia blend).
Pancreatic lipase inhibition was highest in F2 (G. parvifolia) due to high total phenolic content (TPC) and total flavonoid content (TFC) F1 (G. gummi-gutta) showed relatively lower lipase inhibition despite high hydroxycitric acid (HCA) content F3 (G. gummi-gutta and G. parvifolia blend) exhibited medium functional performance but high sensory acceptance
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
In vitro study of a food formulation with no human efficacy data, animal models, or clinical outcomes; demonstrates proof-of-concept for pancreatic lipase inhibition but requires bioavailability and in vivo validation.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Obesity is a serious global health concern associated with metabolic disorders and reduced life expectancy. Thus, food technology research has prioritized the formulation of functional foods that are safe, cost-effective, and capable of promoting long-term weight management. Garcinia gummi-gutta and Garcinia parvifolia were found to have anti-obesity properties due to their bioactive compound constituents that comprise xanthones, hydroxycitric acid (HCA), and diverse phenolic compounds. However, their use in functional gummy formulations is still limited. This study aimed to analyze the sensory acceptability, examine the physicochemical properties and investigate the anti-obesity potential of the formulated G. gummi-gutta and G. parvifolia gummies. Sensory evaluation was carried out using a 7-point hedonic scale to evaluate aroma, taste, texture, appearance, and overall acceptability. Physicochemical analyses included texture, moisture content, pH, total soluble solids (TSS), total phenolic content (TPC), and total flavonoid content (TFC). The anti-obesity potential of the formulations was evaluated using an in vitro pancreatic lipase inhibition assay. Physicochemical results showed that the moisture content of gummy did not vary among the formulations, but inclusion of Garcinia affected the texture, pH, TSS, TPC, and TFC. The pancreatic lipase inhibition was the highest in F2 (G. parvifolia), which is due to its high TPC and TFC. F1 (G. gummi-gutta) had relatively lower lipase inhibition even though G. gummi-gutta had high HCA content. F3 (G. gummi-gutta and G. parvifolia) exhibited a medium functional performance despite having a high sensory acceptance. In conclusion, it was found that F3 (G. gummi-gutta and G. parvifolia) will be preferable to the consumers whereas F2 (G. parvifolia) has a greater anti-obesity effect. However, further research is needed to examine the optimized formulation, stability of bioactive compounds, their bioavailability, and physiological effects.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.